Off-Label Tensions: FDA’s Contraindication Authority Questioned At Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Panel narrows FDA’s question on contraindication of epidural administration of injectable corticosteroids; reimbursement concerns among worries about even just strengthening the warning.